Published in Clin Microbiol Infect on January 10, 2008
The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace. Front Microbiol (2012) 2.45
The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect Immun (2009) 2.23
Multidrug resistant acinetobacter. J Glob Infect Dis (2010) 1.94
Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis (2009) 1.87
Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol (2009) 1.75
Photodynamic therapy for Acinetobacter baumannii burn infections in mice. Antimicrob Agents Chemother (2009) 1.50
The opportunistic human pathogen Acinetobacter baumannii senses and responds to light. J Bacteriol (2010) 1.43
Why are we afraid of Acinetobacter baumannii? Expert Rev Anti Infect Ther (2008) 1.28
Whole transcriptome analysis of Acinetobacter baumannii assessed by RNA-sequencing reveals different mRNA expression profiles in biofilm compared to planktonic cells. PLoS One (2013) 1.20
Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study. Crit Care (2011) 1.10
Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78. BMC Infect Dis (2013) 1.08
Growth of Acinetobacter baumannii in pellicle enhanced the expression of potential virulence factors. PLoS One (2011) 1.03
Biofilm formation at the solid-liquid and air-liquid interfaces by Acinetobacter species. BMC Res Notes (2011) 1.03
Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii. BMC Microbiol (2009) 1.02
H-NS plays a role in expression of Acinetobacter baumannii virulence features. Infect Immun (2013) 0.94
Characterisation of pellicles formed by Acinetobacter baumannii at the air-liquid interface. PLoS One (2014) 0.93
Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother (2013) 0.90
Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit. Indian J Crit Care Med (2013) 0.88
Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside. World J Clin Cases (2014) 0.88
Biofilm Producing Multidrug Resistant Acinetobacter baumannii: An Emerging Challenge. J Clin Diagn Res (2015) 0.86
Differential protection from tobramycin by extracellular polymeric substances from Acinetobacter baumannii and Staphylococcus aureus biofilms. Antimicrob Agents Chemother (2014) 0.84
Analysis of the role of the LH92_11085 gene of a biofilm hyper-producing Acinetobacter baumannii strain on biofilm formation and attachment to eukaryotic cells. Virulence (2016) 0.84
Virstatin inhibits biofilm formation and motility of Acinetobacter baumannii. BMC Microbiol (2014) 0.83
Iron and Acinetobacter baumannii Biofilm Formation. Pathogens (2014) 0.82
Association of blaOXA-23 and bap with the persistence of Acinetobacter baumannii within a major healthcare system. Front Microbiol (2015) 0.82
Draft Genome Sequence of the Biofilm-Hyperproducing Acinetobacter baumannii Clinical Strain MAR002. Genome Announc (2015) 0.81
Antibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: An evidence-based literature review. J Res Pharm Pract (2015) 0.80
Biofilm Formation Caused by Clinical Acinetobacter baumannii Isolates Is Associated with Overexpression of the AdeFGH Efflux Pump. Antimicrob Agents Chemother (2015) 0.80
Relationship between Antibiotic Resistance, Biofilm Formation, and Biofilm-Specific Resistance in Acinetobacter baumannii. Front Microbiol (2016) 0.78
Increased biofilm formation by nontypeable Haemophilus influenzae isolates from patients with invasive disease or otitis media versus strains recovered from cases of respiratory infections. Appl Environ Microbiol (2014) 0.78
Biofilm Formation and Motility Depend on the Nature of the Acinetobacter baumannii Clinical Isolates. Front Public Health (2016) 0.76
In vitro Comparison of Anti-Biofilm Effects against Carbapenem-Resistant Acinetobacter baumannii: Imipenem, Colistin, Tigecycline, Rifampicin and Combinations. Infect Chemother (2015) 0.76
Penetration of intact blood-brain barrier by doripenem. Antimicrob Agents Chemother (2011) 0.76
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options. Front Cell Infect Microbiol (2017) 0.75
Molecular Analysis and Expression of bap Gene in Biofilm-Forming Multi-Drug-Resistant Acinetobacter baumannii. Rep Biochem Mol Biol (2016) 0.75
Imipenem Treatment Induces Expression of Important Genes and Phenotypes in a Resistant Acinetobacter baumannii Isolate. Antimicrob Agents Chemother (2015) 0.75
Outer membrane Protein A plays a role in pathogenesis of Acinetobacter nosocomialis. Virulence (2016) 0.75
Activity of Norspermidine on Bacterial Biofilms of Multidrug-Resistant Clinical Isolates Associated with Persistent Extremity Wound Infections. Adv Exp Med Biol (2016) 0.75
Biofilm may not be Necessary for the Epidemic Spread of Acinetobacter baumannii. Sci Rep (2016) 0.75
Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria? GMS Hyg Infect Control (2017) 0.75
Global dynamic proteome study of a pellicle-forming Acinetobacter baumannii strain. Mol Cell Proteomics (2016) 0.75
Virulence profiles and innate immune responses against highly lethal, multidrug-resistant nosocomial isolates of Acinetobacter baumannii from a tertiary care hospital in Mexico. PLoS One (2017) 0.75
Global assessment of small RNAs reveals a non-coding transcript involved in biofilm formation and attachment in Acinetobacter baumannii ATCC 17978. PLoS One (2017) 0.75
Osmotic compounds enhance antibiotic efficacy against Acinetobacter baumannii biofilm communities. Appl Environ Microbiol (2017) 0.75
Quinolone resistance from a transferable plasmid. Lancet (1998) 11.28
Nuclear hormone receptors and gene expression. Physiol Rev (2001) 4.56
Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob Agents Chemother (1999) 3.85
Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology (1999) 3.49
Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol (2001) 2.73
Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus. EMBO J (1987) 2.67
Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems. Antimicrob Agents Chemother (1998) 2.60
Iron-regulated outer membrane protein OM2 of Vibrio anguillarum is encoded by virulence plasmid pJM1. J Bacteriol (1985) 2.49
Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamase. J Antimicrob Chemother (2003) 2.37
Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis (1996) 2.37
[Estimation of the sample size in clinical and epidemiological investigations]. Med Clin (Barc) (1998) 2.18
Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in beta-lactam antibiotic resistance. J Bacteriol (1999) 2.12
Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania. J Clin Microbiol (1999) 2.11
High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators. J Epidemiol Community Health (1998) 2.08
Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. J Clin Microbiol (2001) 2.06
Characterization of anguibactin, a novel siderophore from Vibrio anguillarum 775(pJM1). J Bacteriol (1986) 1.98
[Cefixime versus amoxicillin plus netilmicin in the treatment of community-acquired non-complicated acute pyelonephritis]. Med Clin (Barc) (1998) 1.95
Nucleotide sequence of a 13.9 kb segment of the 90 kb virulence plasmid of Salmonella typhimurium: the presence of fimbrial biosynthetic genes. Mol Microbiol (1993) 1.89
Brucella endocarditis: clinical, diagnostic, and therapeutic approach. Eur J Clin Microbiol Infect Dis (2003) 1.81
Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes. Antimicrob Agents Chemother (1999) 1.78
Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: a descriptive and comparative study of 219 cases. Ann Rheum Dis (1997) 1.75
Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain. Antimicrob Agents Chemother (2005) 1.73
Modulation of adherence of coagulase-negative staphylococci to Teflon catheters in vitro. Eur J Clin Microbiol (1986) 1.73
Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur J Vasc Endovasc Surg (2009) 1.72
Diarrhea in children under 5 years of age from Ifakara, Tanzania: a case-control study. J Clin Microbiol (2000) 1.72
Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J Antimicrob Chemother (2000) 1.72
Antimicrobial resistance and spread of class 1 integrons among Salmonella serotypes. Antimicrob Agents Chemother (2000) 1.71
Digestive anisakiasis: clinical manifestations and diagnosis according to localization. Rev Esp Enferm Dig (2002) 1.70
Genetic analysis of the iron uptake region of the Vibrio anguillarum plasmid pJM1: molecular cloning of genetic determinants encoding a novel trans activator of siderophore biosynthesis. J Bacteriol (1988) 1.64
Prevalence of Shigella enterotoxins 1 and 2 among Shigella strains isolated from patients with traveler's diarrhea. J Clin Microbiol (1999) 1.63
Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J Clin Microbiol (2005) 1.60
Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia. Clin Infect Dis (2001) 1.59
Dietary patterns and associated lifestyles in preconception, pregnancy and postpartum. Eur J Clin Nutr (2006) 1.58
Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection. Clin Microbiol Infect (2005) 1.56
Uptake and activity of rifapentine in human peritoneal macrophages and polymorphonuclear leukocytes. Eur J Clin Microbiol (1987) 1.55
Extended-spectrum and CMY-type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. Clin Microbiol Infect (2010) 1.55
Evaluation of antimicrobial susceptibility of bacteria containing the qnr gene and FOX-5 beta-lactamase by four automated systems. Clin Microbiol Infect (2005) 1.54
Murine typhus as a common cause of fever of intermediate duration: a 17-year study in the south of Spain. Arch Intern Med (1999) 1.54
Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates. Microbiol Immunol (1998) 1.53
Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA (2001) 1.53
Molecular characterization of the iron transport system mediated by the pJM1 plasmid in Vibrio anguillarum 775. J Biol Chem (1991) 1.53
Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study. Neurology (2004) 1.52
Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis. J Hepatol (1994) 1.49
Cerebrospinal fluid tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and interleukin-8 as diagnostic markers of cerebrospinal fluid infection in neurosurgical patients. Crit Care Med (2000) 1.49
Etiology of solitary pulmonary nodules in patients with human immunodeficiency virus infection. Clin Infect Dis (1997) 1.48
Mortality and hospital stay related to coagulase-negative Staphylococci bacteremia in non-critical patients. J Infect (2012) 1.46
Dual phosphorylation and autophosphorylation in mitogen-activated protein (MAP) kinase activation. Biochem J (1993) 1.45
A regulatory gene, angR, of the iron uptake system of Vibrio anguillarum: similarity with phage P22 cro and regulation by iron. Gene (1990) 1.45
Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis (2002) 1.44
Characterization of the Vibrio anguillarum fur gene: role in regulation of expression of the FatA outer membrane protein and catechols. J Bacteriol (1994) 1.43
Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob Agents Chemother (2011) 1.43
[Pharmacokinetic study of zidovudine in parenteral drug addicts with human immunodeficiency virus infection]. Med Clin (Barc) (1993) 1.41
Accuracy and reliability of pulse oximetry at different arterial carbon dioxide pressure levels. Eur Respir J (2008) 1.41
High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin Microbiol Infect (2007) 1.40
Pharmacokinetics of zidovudine in end-stage renal disease: influence of haemodialysis. AIDS (1992) 1.40
Ventilatory insufficiency due to asbestos-related diffuse pleural fibrosis successfully treated with noninvasive home mechanical ventilation. Respiration (2001) 1.40
Schinzel-Giedion syndrome: report of two sibs. Am J Med Genet (1995) 1.40
Detection of plasmid-mediated quinolone resistance genes in clinical isolates of Enterobacter spp. in Spain. J Clin Microbiol (2009) 1.39
[Usefulness of the disk diffusion method for evaluating the sensitivity of Neisseria meningitidis to penicillin and cefotaxime]. Enferm Infecc Microbiol Clin (1997) 1.39
Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates. J Antimicrob Chemother (1999) 1.39
[Respiratory cryptosporidiosis as first manifestation of AIDS]. Enferm Infecc Microbiol Clin (1996) 1.39
[Diagnostic approach to neoplasms at an internal medicine service]. Med Clin (Barc) (1996) 1.39
Plasmids mediating iron uptake in Vibrio anguillarum strains isolated from turbot in Spain. J Gen Microbiol (1985) 1.39
[Athero-embolic nephropathy. Report of 2 cases]. Med Clin (Barc) (1990) 1.38
Etiology of traveller's diarrhea in Spanish travellers to developing countries. Eur J Epidemiol (1993) 1.38
Non-invasive interventions for improving well-being and quality of life in patients with lung cancer. Cochrane Database Syst Rev (2004) 1.38
[Incidence of enteropathogens in patients with human immunodeficiency virus infection]. Med Clin (Barc) (1994) 1.38
Comparison of acquisition of resistant microorganisms and infections in critically-ill patients with and without malignancies. Minerva Anestesiol (2013) 1.38
Uptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cells. Antimicrob Agents Chemother (1992) 1.37
Postoperative spondylodiskitis: etiology, clinical findings, prognosis, and comparison with nonoperative pyogenic spondylodiskitis. Clin Infect Dis (1999) 1.37
Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Clin Microbiol Infect (2005) 1.36
Qnr-like pentapeptide repeat proteins in gram-positive bacteria. J Antimicrob Chemother (2008) 1.36
Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. J Hosp Infect (2011) 1.33
Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J Urol (2007) 1.33
Decreased permeability and enhanced proton-dependent active efflux in the development of resistance to quinolones in Morganella morganii. Int J Antimicrob Agents (2000) 1.33
Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal beta-lactamase and showing altered porin profiles. Antimicrob Agents Chemother (2000) 1.32
Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1. Antimicrob Agents Chemother (2007) 1.31
Identification of Acinetobacter species. J Clin Microbiol (1994) 1.31
Use of a three-day estimated food record, a 72-hour recall and a food-frequency questionnaire for dietary assessment in a Mediterranean Spanish population. Clin Nutr (2001) 1.28
Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Clin Microbiol Infect (2007) 1.28
Increased production of the siderophore anguibactin mediated by pJM1-like plasmids in Vibrio anguillarum. Infect Immun (1988) 1.28
CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii. Antimicrob Agents Chemother (2009) 1.27
Cholera outbreak in southern Tanzania: risk factors and patterns of transmission. Emerg Infect Dis (2001) 1.27